2m 2m 2m 2m 2m 2m 2m
Cerus (CERS)
NASDAQ
$2.33-$0.06 (-2.72%)
Price as of Oct 22, 2026 7:30 PM EDT- $481.6MMarket Cap
- 59.33%1-Year Change
- Medical DevicesIndustry
Cerus (CERS)
$2.33-$0.06 (-2.72%)
CERS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.39 | ||
Change | +$0.08 (+3.46%) | ||
Open | $2.31 | ||
High | $2.39 | ||
Low | $2.30 | ||
Previous Close | $2.31 | ||
Volume | 1,872,809 | ||
30-Day Average Volume | 1,913,157 | ||
1-Week Change | 6.70% | ||
1-Month Change | -6.64% | ||
1-Year Change | 59.33% | ||
3-Year Change | 88.19% | ||
5-Year Change | -62.18% | ||
Fundamentals | |||
Shares Outstanding | 201.5M | ||
Total Assets | $205.2M | ||
Market Cap | $481.6M | ||
Enterprise Value | $528.6M | ||
Period: QTR TTM FY | |||
Revenue | $57.4M | ||
Net Income | -$2.9M | ||
Free Cash Flow | -$3.5M | ||
EBIT | -$2.8M | ||
EBITDA | -$2.4M | ||
Net Working Capital | $71.5M | ||
EPS | -$0.01 | ||
Enterprise Value/EBITDA | -222 | ||
Enterprise Value/Revenue | 9 | ||
P/B | 7 | ||
P/E | -239 | ||
PEG | N/A | ||
Price/Free Cash Flow | -136 | ||
Price/Operating Cash Flow | -181 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue